Multiminicore myopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:598OMIM:117000G71.2
Who is this for?
Show terms as
4Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Multiminicore myopathy (also known as multiminicore disease, multicore myopathy, or minicore myopathy) is a rare inherited muscle disorder classified among the congenital myopathies. It is characterized by the presence of multiple small areas of disrupted structure (called minicores or multicores) within muscle fibers, visible on muscle biopsy. The disease primarily affects skeletal muscles, leading to muscle weakness and hypotonia (reduced muscle tone), typically presenting in infancy or early childhood. Several clinical forms have been described, including the classic form (the most common), which features axial muscle weakness, scoliosis, and respiratory insufficiency; a form with prominent external ophthalmoplegia (weakness of eye muscles); a form with hand involvement and joint contractures; and a moderate form with generalized weakness. The classic form of multiminicore myopathy is most frequently caused by recessive mutations in the SEPN1 (selenoprotein N) gene or the RYR1 (ryanodine receptor 1) gene. Mutations in RYR1 can also cause other forms of the disease. Less commonly, mutations in MYH7 and other genes have been implicated. The disease predominantly affects the musculoskeletal and respiratory systems. Patients often present with delayed motor milestones, proximal and axial muscle weakness, spinal rigidity, scoliosis, and progressive respiratory compromise that may require ventilatory support. Facial weakness and feeding difficulties may also occur in early life. Cardiac involvement is uncommon but has been reported in certain genetic subtypes. There is currently no cure for multiminicore myopathy, and treatment is supportive and multidisciplinary. Management focuses on physical therapy and rehabilitation to maintain mobility, orthopedic interventions for scoliosis, and respiratory monitoring with ventilatory support when needed. Nutritional support may be required in patients with feeding difficulties. Regular cardiac screening may be recommended depending on the genetic subtype. Genetic counseling is important for affected families. With appropriate supportive care, many patients maintain ambulation, though the clinical course and severity can vary significantly depending on the underlying genetic cause and clinical subtype.

Also known as:

Clinical phenotype terms— hover any for plain English:

Minicore myopathyHP:0003789Spinal rigidityHP:0003306Abnormal muscle fiber morphologyHP:0004303Proximal upper limb muscle weaknessHP:0008997External ophthalmoplegiaHP:0000544Malignant hyperthermiaHP:0002047
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Oct 2025An Empirical Study on the Mechanisms of Biopsychosocial Functional Improvement in Patients With Major Depressive Disorder Through Nature-Based Tourism Activities

Shandong Provincial Hospital — NA

TrialRECRUITING
Oct 2024Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina — PHASE4

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Multiminicore myopathy.

View clinical trials →

No actively recruiting trials found for Multiminicore myopathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Multiminicore myopathy community →

Specialists

4 foundView all specialists →
HM
hayati Yaakup, MBBS
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Multiminicore myopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Multiminicore myopathyForum →

No community posts yet. Be the first to share your experience with Multiminicore myopathy.

Start the conversation →

Latest news about Multiminicore myopathy

Disease timeline:

New recruiting trial: An Empirical Study on the Mechanisms of Biopsychosocial Functional Improvement in Patients With Major Depressive Disorder Through Nature-Based Tourism Activities

A new clinical trial is recruiting patients for Multiminicore myopathy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Multiminicore myopathy

What is Multiminicore myopathy?

Multiminicore myopathy (also known as multiminicore disease, multicore myopathy, or minicore myopathy) is a rare inherited muscle disorder classified among the congenital myopathies. It is characterized by the presence of multiple small areas of disrupted structure (called minicores or multicores) within muscle fibers, visible on muscle biopsy. The disease primarily affects skeletal muscles, leading to muscle weakness and hypotonia (reduced muscle tone), typically presenting in infancy or early childhood. Several clinical forms have been described, including the classic form (the most common),

Which specialists treat Multiminicore myopathy?

4 specialists and care centers treating Multiminicore myopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.